Compas on July 27 announced a rebranding that reflects future growth of the organization and expansion of its capabilities.
Novartis CEO Joe Jimenez will step down on Feb. 1, 2018, and hand over the top leadership role of the Swiss company to drug development chief Vas Narasimhan.
July 21, 2017 By Alex Keown, BioSpace.com Breaking News Staff LONDON – After a period of uncertainty, AstraZeneca (AZN) Chief Executive Officer Pascal Soriot finally broke his silence to squelch rumors he was departing the company and urged his employees to remain focused on the company’s goals. In an internal memo sent earlier this week […]
J. Michael Pearson is out at Valeant Pharmaceuticals and the company is looking for a new chief executive officer.
BOSTON – The verdict is in and Lars Sørensenhief executive officer of the Denmark-based diabetes drugmaking giant Novo Nordisk (NVO), has been named the world’s best-performing CEO, according to the Harvard Business Review. This year, the HBR selected Sørensen as the number one chief executive for its annual “100 Best Performing CEOs.” Sørensen, who […]